SAFETY AND IMMUNOGENICITY OF BNT162B2 MRNA COVID-19 VACCINE AMONG ADOLESCENTS WITH RHEUMATIC DISEASES TREATED WITH IMMUNOMODULATORY MEDICATIONS

被引：0
|
作者：
Heshin-Bekenstein, M. [1 ,2 ]
Ziv, A. [2 ,3 ]
Toplak, N. [4 ]
Hagin, D. [2 ,5 ]
Kadishevich, D. [6 ]
Butbul, Y. [7 ]
Saiag, E. [8 ]
Shefer, G. [9 ]
Sharon, O. [9 ]
Pel, S. [10 ]
Elkayam, O. [2 ,10 ]
Uziel, Y. [2 ,3 ]
机构：
[1] Dana Dwek Childrens Hosp, Pediat Rheumatol Serv, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Meir Med Ctr, Pediat Rheumatol Unit, Kefar Sava, Israel
[4] Univ Childrens Hosp, Univ Med Ctr Ljubljana, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia
[5] Tel Aviv Med Ctr & Sch Med, Allergy & Clin Immunol Unit, Tel Aviv, Israel
[6] Meir Med Ctr, Pediat, Kefar Sava, Israel
[7] Ruth Rappaport Childrens Hosp, Pediat Rheumatol Serv, Rambam Med Ctr, Haifa, Israel
[8] Tel Aviv Sourasky Med Ctr, Hosp Management, Informat & Operat Branch, Tel Aviv, Israel
[9] Tel Aviv Sourasky Med Ctr, Dept Endocrinol Metab & Hypertens, Tel Aviv, Israel
[10] Tel Aviv Sourasky Med Ctr, Dept Rheumatol, Tel Aviv, Israel
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.4691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0258
引用
收藏
页码：370 / 371
页数：2
相关论文
共 50 条
  • [1] Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications
    Heshin-Bekenstein, Merav
    Ziv, Amit
    Toplak, Natasa
    Hagin, David
    Kadishevich, Danielle
    Butbul, Yonatan A.
    Saiag, Esther
    Kaufman, Alla
    Shefer, Gabi
    Sharon, Orli
    Pel, Sara
    Elkayam, Ori
    Uziel, Yosef
    RHEUMATOLOGY, 2022, 61 (11) : 4263 - 4272
  • [2] Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
    Chantasrisawad, Napaporn
    Puthanakit, Thanyawee
    Tangsathapornpong, Auchara
    Techasaensiri, Chonnamet
    Phongsamart, Wanatpreeya
    Suwanpakdee, Detchvijitr
    Jaruampornpan, Peera
    Sophonphan, Jiratchaya
    Suntarattiwong, Piyarat
    Chotpitayasunondh, Tawee
    VACCINES, 2022, 10 (06)
  • [3] Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients
    Ligumsky, Hagai
    Safadi, Esraa
    Etan, Tal
    Vaknin, Noam
    Waller, Manuel
    Croll, Assaf
    Nikolaevski-Berlin, Alla
    Greenberg, Inbal
    Halperin, Tami
    Wasserman, Asaf
    Galazan, Lior
    Arber, Nadir
    Wolf, Ido
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (02): : 203 - 209
  • [4] Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
    Frenck, Robert W., Jr.
    Klein, Nicola P.
    Kitchin, Nicholas
    Gurtman, Alejandra
    Absalon, Judith
    Lockhart, Stephen
    Perez, John L.
    Walter, Emmanuel B.
    Senders, Shelly
    Bailey, Ruth
    Swanson, Kena A.
    Ma, Hua
    Xu, Xia
    Koury, Kenneth
    Kalina, Warren V.
    Cooper, David
    Jennings, Timothy
    Brandon, Donald M.
    Thomas, Stephen J.
    Tureci, Ozlem
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 239 - 250
  • [5] Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents
    Choe, Young June
    Yi, Seonju
    Hwang, Insob
    Kim, Jia
    Park, Young-Joon
    Cho, Eunhee
    Jo, Myoungyoun
    Lee, Hyunju
    Choi, Eun Hwa
    VACCINE, 2022, 40 (05) : 691 - 694
  • [6] Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy
    Diamantopoulos, Panagiotis T.
    Kontandreopoulou, Christina-Nefeli
    Gkoufa, Aikaterini
    Solomou, Elena
    Anastasopoulou, Amalia
    Palli, Eleni
    Kouzis, Panagiotis
    Bouros, Spyros
    Samarkos, Mihalis
    Magiorkinis, Gkikas
    Gogas, Helen
    CANCERS, 2022, 14 (15)
  • [7] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers
    Rojkovich, Bernadette
    Nemeth, Dora
    Torok, Eszter
    Szabo, Bernadette
    Pinter, Agnes
    Juhasz, Istvan
    Weidl, Marton
    Lanyi, Eva
    Pavel-Szecsko, Judit
    Lazar, Imre
    Perduk, Andras
    Reiter, Jozsef
    Nagy, Gyorgy
    Nagy, Erzsebet
    Geher, Pal
    ORVOSI HETILAP, 2021, 162 (39) : 1551 - 1557
  • [8] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases
    Ziv, Amit
    Heshin-Bekenstein, Merav
    Haviv, Ruby
    Kivity, Shaye
    Netzer, Doron
    Yaron, Shlomit
    Schur, Yoav
    Egert, Tsipi
    Egert, Yona
    Sela, Yaron
    Hashkes, Philip J.
    Uziel, Yosef
    RHEUMATOLOGY, 2023, 62 (SI2) : SI145 - SI151
  • [9] Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine Among Adolescents with Juvenile-onset Inflammatory Rheumatic Diseases
    Ziv, Amit
    Heshin-Bekenstein, Merav
    Haviv, Ruby
    Kivity, Shaye
    Netzer, Doron
    Yaron, Shlomit
    Schur, Yoav
    Egert, Tsipi
    Egert, Yona
    Sela, Yaron
    Hashkes, Philip
    Uziel, Yosef
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3852 - 3853
  • [10] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27): : 2603 - 2615
12345